Dr. Hayes Discusses Anti-Estrogen Therapy Beyond 5 Years in Breast Cancer | OncLive

Dr. Hayes Discusses Anti-Estrogen Therapy Beyond 5 Years in Breast Cancer

May 31, 2017

Daniel F. Hayes, MD, professor of University of Michigan Comprehensive Cancer Center, discusses anti-estrogen therapy beyond 5 years in breast cancer.

Daniel F. Hayes, MD, professor of University of Michigan Comprehensive Cancer Center, discusses anti-estrogen therapy beyond 5 years in breast cancer.

One of the big questions facing the breast cancer field, Hayes says, is what to do about women who have made it to 5 years on an anti-estrogen therapy.

There are now 4 trials to suggest that continued anti-estrogen therapy beyond 5 years suppresses late recurrence.


x